• OPEN AN ACCOUNT
Indian Indices
Sensex
76,515.43 362.57
( 0.48%)
Global Indices
Nasdaq
53,423.66 -283.45
(-0.53%)
Dow Jones
7,737.34 -31.37
(-0.40%)
Hang Seng
65,002.68 788.20
(1.23%)
Nikkei 225
10,828.70 -2.82
(-0.03%)
Forex
USD-INR
94.48 -0.24
(-0.26%)
EUR-INR
109.71 0.00
(0.00%)
GBP-INR
127.63 -0.19
(-0.15%)
JPY-INR
0.60 0.01
(1.60%)

EQUITY - MARKET SCREENER

Gujarat Themis Biosyn Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
506879
INE942C01045
79.7351477
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUJTHEM
110.09
5359
EPS(TTM)
Face Value()
Div & Yield %
3.74
1
0.14
 

radhagobind commercial ltd
Pavna Industries consolidated net profit rises 43.53% in the March 2026 quarter
May 29,2026
Net profit of Pavna Industries rose 43.53% to Rs 2.44 crore in the quarter ended March 2026 as against Rs 1.70 crore during the previous quarter ended March 2025. Sales declined 17.79% to Rs 54.45 crore in the quarter ended March 2026 as against Rs 66.23 crore during the previous quarter ended March 2025.

For the full year,net profit declined 37.45% to Rs 4.61 crore in the year ended March 2026 as against Rs 7.37 crore during the previous year ended March 2025. Sales declined 3.63% to Rs 297.04 crore in the year ended March 2026 as against Rs 308.24 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales54.4566.23 -18 297.04308.24 -4
OPM %14.7711.34 -9.6710.73 -
PBDT6.585.94 11 24.8224.20 3
PBT2.832.59 9 10.5011.16 -6
NP2.441.70 44 4.617.37 -37